Descubre nuestro grupo:

PAÍSES

2020

2020

  • 2020 - 09 - 03

    A.MENARINI DIAGNOSTICS and BIOACTIVA DIAGNOSTICA GMBH SIGN AN EXCLUSIVE AGREEMENT FOR LIOFERON® TB/LTBI, A TEST TO DIAGNOSE LATENT TUBERCULOSIS INFECTION

  • 2020 - 09 - 01

    ralesci Congresses with "Zero Impact®" on the environmentive drug for chronic hyperuricaemia in gout.D VitaPCR® POC instrument.

  • 2020 - 07 - 24

    A.Menarini Diagnostics Announces Agreement with Skyla Corporation in the area of Point of Care Testing

  • 2020 - 07 - 16

    Menarini Diagnostics announces Technology Transfer Agreement to develop its own COVID 19 RT PCR assay

  • 2020 - 04 - 15

    Menarini dona 17.000 test de diagnóstico rápido frente a la COVID-19

  • 2020 - 04 - 01

    Credo Diagnostics Biomedical And A. Menarini Diagnostics Sign An Exclusive Distribution Agreement For Sars-cov-2 Assay On The Vitapcrtm Platform

  • 2020 - 02 - 01

    MEDLAB Middle East

  • 2020 - 02 - 01

    ATTD 2020

News Archive